Burning Rock Biotech Income Statement (2019-2026) | BNR

Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
19.71M19.65M23.12M21.38M19.53M21.74M20.62M20.75M20.17M17.48M17.05M17.40M18.65M18.33M17.27M18.34M20.74M18.49M18.06M15.65M
Cost of Revenue (Quarter)
5.74M5.43M6.58M7.56M7.20M6.47M5.94M6.37M6.32M5.71M6.05M5.53M5.52M5.24M5.01M4.92M5.65M4.60M3.97M4.34M
Gross Profit (Quarter)
13.97M14.21M16.54M13.82M12.33M15.27M14.68M14.38M13.85M11.78M11.00M11.87M13.13M13.09M12.25M13.42M15.09M13.88M14.10M11.31M
Operating items
Research & Development (Quarter)
-16.74M-10.81M-17.69M-18.85M-13.75M-15.38M-14.62M-13.75M-13.21M-11.47M-10.30M-9.14M-8.94M-7.00M-7.15M-5.57M-6.95M-5.83M-4.99M-4.00M
Share-based Compensation (IS) (Quarter)
12.91M8.28M9.50M12.63M11.70M11.38M12.89M11.43M5.40M10.15M9.91M9.70M9.41M1.41M1.12M0.63M
Selling, General & Administrative (Quarter)
-17.99M-18.05M-22.21M-22.36M-22.44M-20.18M-19.24M-18.64M-9.59M-16.27M-17.12M-13.67M-12.77M-4.68M-5.11M-4.31M-4.39M-4.45M-4.53M-4.07M
Other Operating Expenses (Quarter)
-10.54M-16.20M-14.06M-15.77M-12.35M-9.47M-10.11M-7.01M-6.76M-11.21M-5.62M-5.84M-6.30M-5.95M
Operating Expenses (Quarter)
-45.27M-40.76M-56.10M-55.28M-51.97M-48.25M-46.21M-41.82M-32.57M-36.28M-34.43M-29.30M-28.44M-18.59M-23.48M-15.52M-16.70M-16.15M-15.82M-14.04M
Operating Income (Quarter)
-31.29M-26.55M-39.56M-41.47M-39.63M-32.98M-31.53M-27.44M-18.72M-24.51M-23.43M-17.43M-15.30M-5.50M-11.22M-2.09M-1.60M-2.27M-1.72M-2.73M
EBIT (Quarter)
-31.29M-26.55M-39.56M-41.42M-39.63M-32.98M-31.53M-27.55M-19.38M-24.51M-23.43M-17.43M-15.36M-5.50M-11.22M-2.09M-1.60M-2.25M-1.72M-2.72M
Non-operating items
Non Operating Investment Income (Quarter)
Other Non Operating Income (Quarter)
-0.09M0.00M-0.12M-0.12M0.09M0.19M0.05M0.09M-0.02M0.06M0.02M0.06M-0.01M-0.58M0.60M-0.09M-0.08M0.00M-0.29M0.04M
Net income details
EBT (Quarter)
-31.29M-26.39M-39.59M-41.23M-39.12M-32.54M-31.07M-26.91M-18.04M-23.92M-22.70M-16.81M-14.84M-5.07M-10.41M-1.83M-1.32M-2.33M-2.07M-2.50M
Tax Provisions (Quarter)
-0.25M-0.07M0.18M-0.01M-0.28M-0.06M-0.06M-0.06M-0.15M-0.03M-0.03M-0.03M-0.73M-0.03M-0.03M-0.03M-0.12M-0.03M
Profit After Tax (Quarter)
-31.55M-26.46M-39.41M-41.23M-39.14M-32.54M-31.35M-26.98M-18.10M-23.98M-22.85M-16.84M-14.87M-5.09M-11.14M-1.86M-1.35M-2.35M-2.20M-2.53M
Income from Continuing Operations (Quarter)
-31.04M-26.33M-39.77M-41.18M-39.11M-32.54M-30.80M-26.96M-18.61M-23.86M-22.55M-16.79M-14.87M-5.04M-9.68M-1.80M-1.29M-2.28M-1.95M-2.46M
Consolidated Net Income (Quarter)
-31.04M-39.77M-41.18M-39.11M-30.80M-26.96M-18.61M-22.55M-14.87M-9.68M-1.80M-2.28M-1.95M-2.46M
Income towards Parent Company (Quarter)
-31.04M-39.77M-41.18M-39.11M-30.80M-26.96M-18.61M-22.55M-14.87M-9.68M-1.80M-2.28M-1.95M-2.46M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-31.55M-26.46M-39.41M-41.23M-39.14M-32.54M-31.35M-26.98M-18.10M-23.98M-22.85M-16.84M-14.87M-5.09M-11.32M-1.86M-1.35M-2.35M-2.20M-2.53M
Additional items
EPS (Basic) (Quarter)
-3.64-3.04-4.73-4.47-3.74-3.62-3.17-10.45-2.82-2.69-0.20-0.86-0.29-0.13-0.02-0.01-0.03-0.02-0.03
EPS (Diluted) (Quarter)
-3.64-4.54-4.48-3.62-2.69-0.13-0.02
Shares Outstanding (Quarter)
8.68M8.69M8.72M8.75M8.71M8.66M8.51M1.73M8.51M8.51M85.22M17.32M17.32M85.61M90.29M90.36M90.33M88.98M87.87M
Shares Outstanding (Diluted) (Quarter)
8.67M8.67M8.69M8.69M8.74M8.74M8.66M8.66M8.66M8.66M8.51M8.51M8.51M8.51M85.61M85.61M85.61M85.61M88.98M88.98M
EBITDA (Quarter)
-36.96M-25.50M-43.29M-41.72M-34.70M-29.64M-32.21M-27.80M-16.05M-24.25M-23.27M-16.75M-14.74M-5.67M-10.31M-1.87M-1.39M-2.60M-2.49M-2.99M
Interest Expenses (Quarter)
-0.09M-0.06M-0.01M-0.00M-0.00M-0.00M
Tax Rate (Quarter)
0.81%0.25%-0.46%0.03%0.89%0.23%0.34%0.26%0.67%0.15%0.18%0.57%6.99%1.69%2.58%1.29%6.03%1.36%